Please turn JavaScript on
Hematologic Oncology Update icon

Hematologic Oncology Update

Subscribe in seconds and receive Hematologic Oncology Update's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.

You can select the updates using tags or topics and you can add as many websites to your feed as you like.

And the service is entirely free!

Follow Hematologic Oncology Update: Hematologic Oncology Update

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.33 / day

Message History

Featuring an interview with Dr Matthew Lunning, including the following topics:

Tafasitamab for follicular lymphoma (0:00)frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51)

CME information and select publicatio...


Read full story

Featuring perspectives from Prof Chan Chea and Dr Matthew Matasar, including the following topics:

Introduction (0:00)Prologue: Saturday Night Fever (1:35)Baby Boomers' Guide to Mechanisms of Action (3:07)Second-Line Treatment (12:36)Complications Associated with Bispecific Antibodies (23:41)Case Presentations (25:52)New Bispecific T-Cell Engagers — Surovatamig (26:24)Othe...

Read full story

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics:

Multiple Myeloma (0:00)Introduction: ESMO 2026; Recent FDA Approvals (1:53)Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46)Bispecific Antibodies — Dr Lonial (19:16)Antibody-Drug Conjugates — Dr Richardson (37:08)Up-Front Treatment; Cereblon E3 Ligase Modulators ...

Read full story

Featuring an interview with Dr Matthew Lunning, including the following topics:

Bispecific antibody/antibody-drug conjugate combinations (0:00)A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07)

CME information and select publications...


Read full story

Featuring a presentation by Dr Matthew Matasar, including the following topics:

Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)Clinician ...

Read full story